Free Trial

InnovAge (INNV) Stock Price, News & Analysis

0.00 (0.00%)
(As of 05/24/2024 ET)
Today's Range
50-Day Range
52-Week Range
21,346 shs
Average Volume
38,206 shs
Market Capitalization
$611.96 million
P/E Ratio
Dividend Yield
Price Target

InnovAge MarketRank™ Stock Analysis

Analyst Rating
2.00 Rating Score
44.4% Upside
$6.50 Price Target
Short Interest
1.73% of Float Sold Short
Dividend Strength
News Sentiment
0.38mentions of InnovAge in the last 14 days
Based on 4 Articles This Week
Insider Trading
Proj. Earnings Growth

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.45 out of 5 stars

Medical Sector

875th out of 917 stocks

Health Services Industry

10th out of 10 stocks

INNV stock logo

About InnovAge Stock (NASDAQ:INNV)

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.

INNV Stock Price History

INNV Stock News Headlines

InnovAge Holding Corp (INNV)
INNV InnovAge Holding Corp.
InnovAge Holding: A Cautious Hold Amidst Mixed Financial Signals
Recap: InnovAge Holding Q2 Earnings
InnovAge Holding Corp INNV
InnovAge Revenue Ticks Up, But Challenges Remain
See More Headlines
Receive INNV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InnovAge and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Fiscal Year End
Next Earnings (Estimated)

Industry, Sector and Symbol

Health services
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
2 Analysts


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
$688.09 million
Book Value
$2.11 per share


Free Float
Market Cap
$611.96 million
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Mr. Patrick Blair (Age 53)
    President & CEO
    Comp: $1.51M
  • Ms. Nicole D'Amato (Age 45)
    Chief Legal Officer & Corporate Secretary
    Comp: $678.76k
  • Dr. Richard A. Feifer FACP (Age 57)
    M.D., M.P.H., Chief Medical Officer
    Comp: $588.97k
  • Mr. Edward Moore Kennedy Jr. (Age 63)
    J.D., Independent Director
    Comp: $100k
  • Hon. Marilyn Barbour Tavenner M.H.A. (Age 62)
    R.N., Independent Director
    Comp: $120k
  • Mr. Benjamin Crowninshield Adams (Age 60)
    Chief Financial Officer
  • Ms. Christine Bent (Age 53)
    Chief Operations Officer
  • Ms. Cara Babachicos
    Chief Information Officer
  • Mr. Ryan Kubota
    Director of Investor Relations
  • Ms. Olivia Patton
    Chief Compliance Officer

INNV Stock Analysis - Frequently Asked Questions

Should I buy or sell InnovAge stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for InnovAge in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" INNV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in INNV, but not buy additional shares or sell existing shares.
View INNV analyst ratings
or view top-rated stocks.

What is InnovAge's stock price target for 2024?

2 Wall Street analysts have issued 12-month price targets for InnovAge's shares. Their INNV share price targets range from $6.00 to $7.00. On average, they expect the company's share price to reach $6.50 in the next year. This suggests a possible upside of 44.4% from the stock's current price.
View analysts price targets for INNV
or view top-rated stocks among Wall Street analysts.

How have INNV shares performed in 2024?

InnovAge's stock was trading at $6.00 at the beginning of 2024. Since then, INNV stock has decreased by 25.0% and is now trading at $4.50.
View the best growth stocks for 2024 here

When is InnovAge's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, September 10th 2024.
View our INNV earnings forecast

How were InnovAge's earnings last quarter?

InnovAge Holding Corp. (NASDAQ:INNV) announced its quarterly earnings data on Monday, February, 5th. The company reported ($0.03) EPS for the quarter, meeting the consensus estimate of ($0.03). The firm had revenue of $188.90 million for the quarter, compared to analysts' expectations of $181.51 million. InnovAge had a negative net margin of 4.16% and a negative trailing twelve-month return on equity of 10.51%. During the same period last year, the company posted ($0.07) EPS.

What guidance has InnovAge issued on next quarter's earnings?

InnovAge issued an update on its FY 2024 earnings guidance on Wednesday, May, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $725.0 million-$775.0 million, compared to the consensus revenue estimate of $755.3 million.

When did InnovAge IPO?

InnovAge (INNV) raised $301 million in an initial public offering on Thursday, March 4th 2021. The company issued 16,700,000 shares at a price of $17.00-$19.00 per share. J.P. Morgan, Barclays, Goldman Sachs and Citigroup acted as the underwriters for the IPO and Baird, William Blair, Piper Sandler, Capital One Securities, Loop Capital Markets, Siebert Williams Shank and Roberts & Ryan were co-managers.

Who are InnovAge's major shareholders?

InnovAge's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (1.36%) and Kent Lake Capital LLC (1.29%).

How do I buy shares of InnovAge?

Shares of INNV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:INNV) was last updated on 5/25/2024 by Staff

From Our Partners